- Home
- PPBT vs XWEL Comparison
PPBT vs XWEL Comparison
Compare PPBT & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- XWEL
- Stock Information
- Founded
- PPBT 2010
- XWEL 2006
- Country
- PPBT Israel
- XWEL United States
- Employees
- PPBT N/A
- XWEL N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- XWEL Other Consumer Services
- Sector
- PPBT Health Care
- XWEL Consumer Discretionary
- Exchange
- PPBT Nasdaq
- XWEL Nasdaq
- Market Cap
- PPBT 6.2M
- XWEL 4.7M
- IPO Year
- PPBT N/A
- XWEL N/A
- Fundamental
- Price
- PPBT $2.53
- XWEL $0.97
- Analyst Decision
- PPBT Strong Buy
- XWEL
- Analyst Count
- PPBT 1
- XWEL 0
- Target Price
- PPBT $33.00
- XWEL N/A
- AVG Volume (30 Days)
- PPBT 18.2K
- XWEL 49.5K
- Earning Date
- PPBT 08-15-2025
- XWEL 08-13-2025
- Dividend Yield
- PPBT N/A
- XWEL N/A
- EPS Growth
- PPBT N/A
- XWEL N/A
- EPS
- PPBT N/A
- XWEL N/A
- Revenue
- PPBT N/A
- XWEL $32,194,000.00
- Revenue This Year
- PPBT N/A
- XWEL N/A
- Revenue Next Year
- PPBT N/A
- XWEL N/A
- P/E Ratio
- PPBT N/A
- XWEL N/A
- Revenue Growth
- PPBT N/A
- XWEL 1.33
- 52 Week Low
- PPBT $2.00
- XWEL $0.70
- 52 Week High
- PPBT $13.95
- XWEL $2.70
- Technical
- Relative Strength Index (RSI)
- PPBT 56.04
- XWEL 54.46
- Support Level
- PPBT $2.35
- XWEL $0.90
- Resistance Level
- PPBT $2.58
- XWEL $1.05
- Average True Range (ATR)
- PPBT 0.12
- XWEL 0.08
- MACD
- PPBT 0.02
- XWEL 0.00
- Stochastic Oscillator
- PPBT 84.38
- XWEL 50.00
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.